A Developmental Cannabis Review Framed Puberty as a Vulnerability Question, Not an Individual Prediction
A 2008 review considered puberty a potentially vulnerable period for cannabinoid exposure based on brain and endocannabinoid-system maturation. Its synthesis of human and animal evidence does not determine the outcome of an individual adolescent's exposure.
Developmental stage was part of the hypothesis
The review connected ongoing maturation with possible susceptibility to disruption. That supplies a biological rationale for comparing developmental periods. It does not identify a precise human age at which all vulnerability begins or ends.
Human and animal evidence had different strengths
Experimental animal exposure can investigate defined regimens and mechanisms. Human associations can address relevant populations while requiring care about other influences and exposure measurement. Findings from these evidence types should not be merged into a single causal estimate without qualification.
Possible lasting effects need specific outcomes
The source discussed cognition, psychiatric vulnerability and later substance-use concerns. These are different outcomes with different evidentiary requirements. A developmental mechanism does not independently demonstrate every proposed consequence or establish its frequency.
Interpreting the evidence
The review supports retaining age and developmental context in a research interpretation. It does not provide a personal diagnosis, deterministic prognosis or proof that every early user experiences lasting harm. Its historical synthesis should not be presented as a current risk estimate for all products.
Related reading: interpreting cannabis tolerance claims.
Research reference
Schneider M (2008). Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addiction biology. doi:10.1111/j.1369-1600.2008.00110.x.
This analysis draws on the supplied review abstract.
